DYE & DURHAM LTD (DND.) - Wednesday, Nov 13, 2024
Investigation into the company revealed issues such as misleading revenue pull forwards, high churn rates, and a significant drop in log-in traffic
Mayne Pharma (MYX AU): The Scheme Booklet Should Calm Nerves
The scheme booklet should reassure that Cosette is not contesting the MAC clause. Recent events should help quell previous retail opposition to the...
No more insights